BioCentury
ARTICLE | Clinical News

EntreMed preclinical data

April 25, 2005 7:00 AM UTC

In a mouse model of angiogenesis, proteinase activated receptor (PAR) 2led to >80% dose-dependent inhibition of angiogenesis. Data were presented at the American Association of Cancer Research meeting...